RE:RE:RE:No US, No problem IMOIf a large LP wanted the APP tech, without a doubt they would target IBS first. Control of the US market would be the immediate goal.
Next domino to fall would be Sproutly, to gain EU market rights and take advantage of the product development done in Canada.
Dr. Sen and his colleagues have done great work on the tech, they should be proud of themselves. But he is also a serial entrpreneur; I have no doubt he would sell if it met his price.
For the record I would be ecstatic if Bruce knocked on Sen's door lol